Back to Search Start Over

Plasma coenzyme Q10 status is impaired in selected genetic conditions

Authors :
Silvia Meavilla
Joan Maynou
Jaume Campistol
Julio Montoya
Plácido Navas
Viruna Neergheen
Guerau Fernandez
María C. Salgado
Delia Yubero
María-Julieta González
Mercè Pineda
Raquel Montero
Angels García-Cazorla
Rafael Artuch
Verónica Delgadillo
Eduardo Ruiz-Pesini
Maria del Mar O’Callaghan
Iain P. Hargreaves
Instituto de Salud Carlos III
European Commission
Gobierno de Aragón
Source :
Digital.CSIC. Repositorio Institucional del CSIC, instname, Zaguán. Repositorio Digital de la Universidad de Zaragoza, SCIENTIFIC REPORTS, r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu, Fundació Sant Joan de Déu, Scientific Reports, Vol 9, Iss 1, Pp 1-8 (2019), r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Publication Year :
2019
Publisher :
Springer Nature, 2019.

Abstract

© The Author(s) 2019.<br />Identifying diseases displaying chronic low plasma Coenzyme Q10 (CoQ) values may be important to prevent possible cardiovascular dysfunction. The aim of this study was to retrospectively evaluate plasma CoQ concentrations in a large cohort of pediatric and young adult patients. We evaluated plasma CoQ values in 597 individuals (age range 1 month to 43 years, average 11 years), studied during the period 2005–2016. Patients were classified into 6 different groups: control group of healthy participants, phenylketonuric patients (PKU), patients with mucopolysaccharidoses (MPS), patients with other inborn errors of metabolism (IEM), patients with neurogenetic diseases, and individuals with neurological diseases with no genetic diagnosis. Plasma total CoQ was measured by reverse-phase high-performance liquid chromatography with electrochemical detection and ultraviolet detection at 275 nm. ANOVA with Bonferroni correction showed that plasma CoQ values were significantly lower in the PKU and MPS groups than in controls and neurological patients. The IEM group showed intermediate values that were not significantly different from those of the controls. In PKU patients, the Chi-Square test showed a significant association between having low plasma CoQ values and being classic PKU patients. The percentage of neurogenetic and other neurological patients with low CoQ values was low (below 8%). In conclusión, plasma CoQ monitoring in selected groups of patients with different IEM (especially in PKU and MPS patients, but also in IEM under protein-restricted diets) seems advisable to prevent the possibility of a chronic blood CoQ suboptimal status in such groups of patients.<br />This work was supported by grant from the Instituto de Salud Carlos III (ISCIII-FIS PI17/00109, PI17/00021, PI17/01286, PI15/00166 and PI15/01082), the FEDER Funding Program from the European Union, CIBERER-ISCIII and Departamento de Ciencia, Tecnología y Universidad del Gobierno de Aragón (Grupos de Referencia B33_17R).

Details

ISSN :
20452322
Database :
OpenAIRE
Journal :
Digital.CSIC. Repositorio Institucional del CSIC, instname, Zaguán. Repositorio Digital de la Universidad de Zaragoza, SCIENTIFIC REPORTS, r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu, Fundació Sant Joan de Déu, Scientific Reports, Vol 9, Iss 1, Pp 1-8 (2019), r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Accession number :
edsair.doi.dedup.....b5a92c9f23561021c0ff49c6fc5d8c12